Chronic diseases, Multimorbidity, Multimorbidity trajectories, Multimorbidity care models.
AI in Health, Real-World Evidence.
Drug utilisation, Pharmacovigilance.
Personalised medicine, Preventive medicine, Epidemiology, Public health .
EpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain. EpiChron participates in the European Innovation Partnership in Active and Healthy Ageing (EIP on AHA, European Commission), and in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP®, European Medicines Agency).Drug Utilization Work Group, Spanish Society of Family and Community Medicine (semFYC), Barcelona, Spain.
Effectiveness of an intervention in young elderly patients with multimorbidity and polypharmacy for improving drug prescription in Primary Care: a cluster-randomized clinical trial. 2019-2023. Carlos III Health Institute, Madrid, Spain. Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine?.
Web of Science: AAX-4807-2020
PubMed: Ioakeim-Skoufa I